Replies to post #16454 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

opportunity states:
"After reading the responses by Dr Moro it dawned on me that all the negativity is to create a MUCH lower share price for private placements"

It does not surprise me that you come up with another wild conclusion, akin to the same variety that I have multiple aliases. Just to make it perfectly clear. I have 42 shares remaining that are not worth selling. I will never buy another share of bocx regardless of the price.

I just do not think there is any significant market in diagnostics for a universal marker. Dr. Moro has his opinion and I along with a lot of other doctors and websites I have quoted think an ideal marker has to point to the location of the cancer. DR70 and the HAAH universal cancer markers are both on the market for sale as ELISA tests. DR70 has been on the market since about 2002. Initially multiple labs contracted to market DR70 but they all soon ceased making the test available. HAAH has been on the market for nearly two years and it is only available from Panacea Labs. Neither are selling. If Dr. Moro is actually getting some labs to make the RECAF ELISA test available, you will soon be able to see if RECAF can develop a market where other universal markers have failed.

[great-grandma]

Yes, you could say I got spooked, but I feel that my real mistake was putting all my eggs in one basket. One should never do that - especially with a small biotech. At my highest point, I think I had 95% of my portfolio in this stock. I will be the first to admit that I was wrong.

I just had some major surgery. Guard your health, people. There is nothing more important. If RECAF helps us to do that, I will be very, very pleased - no matter how many shares I own.